These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 12548549)

  • 1. Expression of Smad4 in the FaDu cell line partially restores TGF-beta growth inhibition but is not sufficient to regulate fibronectin expression or suppress tumorigenicity.
    Hummer BT; Bartlett C; Henry E; Weissman BE
    J Cell Physiol; 2003 Mar; 194(3):289-302. PubMed ID: 12548549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of tumorigenesis and induction of p15(ink4b) by Smad4/DPC4 in human pancreatic cancer cells.
    Peng B; Fleming JB; Breslin T; Grau AM; Fojioka S; Abbruzzese JL; Evans DB; Ayers D; Wathen K; Wu T; Robertson KD; Chiao PJ
    Clin Cancer Res; 2002 Nov; 8(11):3628-38. PubMed ID: 12429655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad4-independent regulation of p21/WAF1 by transforming growth factor-beta.
    Ijichi H; Otsuka M; Tateishi K; Ikenoue T; Kawakami T; Kanai F; Arakawa Y; Seki N; Shimizu K; Miyazono K; Kawabe T; Omata M
    Oncogene; 2004 Feb; 23(5):1043-51. PubMed ID: 14762439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells.
    Grau AM; Zhang L; Wang W; Ruan S; Evans DB; Abbruzzese JL; Zhang W; Chiao PJ
    Cancer Res; 1997 Sep; 57(18):3929-34. PubMed ID: 9307274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of the tumor suppressor gene Smad4/DPC4 induces p21waf1 expression and growth inhibition in human carcinoma cells.
    Hunt KK; Fleming JB; Abramian A; Zhang L; Evans DB; Chiao PJ
    Cancer Res; 1998 Dec; 58(24):5656-61. PubMed ID: 9865717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smad7 induces tumorigenicity by blocking TGF-beta-induced growth inhibition and apoptosis.
    Halder SK; Beauchamp RD; Datta PK
    Exp Cell Res; 2005 Jul; 307(1):231-46. PubMed ID: 15922743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y; Kyprianou N
    Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smad expression in human atherosclerotic lesions: evidence for impaired TGF-beta/Smad signaling in smooth muscle cells of fibrofatty lesions.
    Kalinina N; Agrotis A; Antropova Y; Ilyinskaya O; Smirnov V; Tararak E; Bobik A
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1391-6. PubMed ID: 15166010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line.
    Fink SP; Swinler SE; Lutterbaugh JD; Massagué J; Thiagalingam S; Kinzler KW; Vogelstein B; Willson JK; Markowitz S
    Cancer Res; 2001 Jan; 61(1):256-60. PubMed ID: 11196171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad4 dependency defines two classes of transforming growth factor {beta} (TGF-{beta}) target genes and distinguishes TGF-{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses.
    Levy L; Hill CS
    Mol Cell Biol; 2005 Sep; 25(18):8108-25. PubMed ID: 16135802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-beta in pancreatic carcinogenesis.
    Jonckheere N; Perrais M; Mariette C; Batra SK; Aubert JP; Pigny P; Van Seuningen I
    Oncogene; 2004 Jul; 23(34):5729-38. PubMed ID: 15184872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smad4 silencing in pancreatic cancer cell lines using stable RNA interference and gene expression profiles induced by transforming growth factor-beta.
    Jazag A; Ijichi H; Kanai F; Imamura T; Guleng B; Ohta M; Imamura J; Tanaka Y; Tateishi K; Ikenoue T; Kawakami T; Arakawa Y; Miyagishi M; Taira K; Kawabe T; Omata M
    Oncogene; 2005 Jan; 24(4):662-71. PubMed ID: 15592526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of the Smad4 gene in acute myelogeneous leukemia and their functional implications in leukemogenesis.
    Imai Y; Kurokawa M; Izutsu K; Hangaishi A; Maki K; Ogawa S; Chiba S; Mitani K; Hirai H
    Oncogene; 2001 Jan; 20(1):88-96. PubMed ID: 11244507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of TGF-beta signaling through Smad2, Smad3 and Smad4.
    Kretschmer A; Moepert K; Dames S; Sternberger M; Kaufmann J; Klippel A
    Oncogene; 2003 Oct; 22(43):6748-63. PubMed ID: 14555988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of mitotic inhibition in corneal endothelium: contact inhibition and TGF-beta2.
    Joyce NC; Harris DL; Mello DM
    Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2152-9. PubMed ID: 12091410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines.
    Fink SP; Mikkola D; Willson JK; Markowitz S
    Oncogene; 2003 Mar; 22(9):1317-23. PubMed ID: 12618756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity to transforming growth factor beta 1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC down-regulation and p21waf1 induction are important early events.
    Malliri A; Yeudall WA; Nikolic M; Crouch DH; Parkinson EK; Ozanne B
    Cell Growth Differ; 1996 Oct; 7(10):1291-304. PubMed ID: 8891333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
    Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
    Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of Smad4 in transformed keratinocytes containing a Ras oncogene leads to hyperactivation of the Ras-dependent Erk signalling pathway associated with progression to undifferentiated carcinomas.
    Iglesias M; Frontelo P; Gamallo C; Quintanilla M
    Oncogene; 2000 Aug; 19(36):4134-45. PubMed ID: 10962574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.